Merit Medical Systems Inc (MMSI)
101.11
-0.17
(-0.17%)
USD |
NASDAQ |
Mar 21, 15:05
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 5.949B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 38.95% |
| Valuation | |
| PE Ratio | 49.81 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.425 |
| Price to Book Value | 4.313 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.5289 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 60.66% |
Profile
Edit
| Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. |
| URL | https://www.merit.com |
| Investor Relations URL | https://www.merit.com/investors/ |
| HQ State/Province | Utah |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Apr. 30, 2025 (est.) |
| Last Earnings Release | Feb. 25, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
Edit
| Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices. |
| URL | https://www.merit.com |
| Investor Relations URL | https://www.merit.com/investors/ |
| HQ State/Province | Utah |
| Sector | Health Care |
| Industry | Health Care Equipment & Supplies |
| Next Earnings Release | Apr. 30, 2025 (est.) |
| Last Earnings Release | Feb. 25, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |